Author Correction: De novo design of RNA-binding proteins with a prion-like domain related to ALS/FTD proteinopathies.Sci Rep. 2020 May 26; 10(1):8746.SR
Abstract
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Links
Pub Type(s)
Published Erratum
Language
eng
PubMed ID
32457403
Citation
Mitsuhashi, Kana, et al. "Author Correction: De Novo Design of RNA-binding Proteins With a Prion-like Domain Related to ALS/FTD Proteinopathies." Scientific Reports, vol. 10, no. 1, 2020, p. 8746.
Mitsuhashi K, Ito D, Mashima K, et al. Author Correction: De novo design of RNA-binding proteins with a prion-like domain related to ALS/FTD proteinopathies. Sci Rep. 2020;10(1):8746.
Mitsuhashi, K., Ito, D., Mashima, K., Oyama, M., Takahashi, S., & Suzuki, N. (2020). Author Correction: De novo design of RNA-binding proteins with a prion-like domain related to ALS/FTD proteinopathies. Scientific Reports, 10(1), 8746. https://doi.org/10.1038/s41598-020-65024-x
Mitsuhashi K, et al. Author Correction: De Novo Design of RNA-binding Proteins With a Prion-like Domain Related to ALS/FTD Proteinopathies. Sci Rep. 2020 May 26;10(1):8746. PubMed PMID: 32457403.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Author Correction: De novo design of RNA-binding proteins with a prion-like domain related to ALS/FTD proteinopathies.
AU - Mitsuhashi,Kana,
AU - Ito,Daisuke,
AU - Mashima,Kyoko,
AU - Oyama,Munenori,
AU - Takahashi,Shinichi,
AU - Suzuki,Norihiro,
Y1 - 2020/05/26/
PY - 2020/5/28/entrez
PY - 2020/5/28/pubmed
PY - 2020/5/28/medline
SP - 8746
EP - 8746
JF - Scientific reports
JO - Sci Rep
VL - 10
IS - 1
N2 - An amendment to this paper has been published and can be accessed via a link at the top of the paper.
SN - 2045-2322
UR - https://www.unboundmedicine.com/medline/citation/32457403/Author_Correction:_De_novo_design_of_RNA_binding_proteins_with_a_prion_like_domain_related_to_ALS/FTD_proteinopathies_
DB - PRIME
DP - Unbound Medicine
ER -
Latest evidence on COVID-19 from PubMed, WHO, CDC.
Visit free Relief Central.
Visit free Relief Central.
Try the Free App:
